Related Experiment Video
Updated: Aug 11, 2026
Experimental Strategies to Bridge Large Tissue Gaps in the Injured Spinal Cord after Acute and Chronic Lesion
Published on: April 5, 2016
Experimental strategies to promote spinal cord regeneration--an integrative perspective
Jan M Schwab1, Klaus Brechtel, Christian-Andreas Mueller
1Institute of Brain Research, Calwer Str. 3, University of Tuebingen, Medical School, Calwerstr. 3, 72076 Tuebingen, Germany. Jschwab@zeus.bwh.harvard.edu
Abstract:
Detailed pathophysiological findings of secondary damage phenomena after spinal cord injury (SCI) as well as the identification of inhibitory and neurotrophic proteins have yielded a plethora of experimental therapeutic approaches. Main targets are (i) to minimize secondary damage progression (neuroprotection), (ii) to foster axon conduction (neurorestoration) and (iii) to supply a permissive environment to promote axonal sprouting (neuroregenerative therapies). Pre-clinical studies have raised hope in functional recovery through the antagonism of growth inhibitors, application of growth factors, cell transplantation, and vaccination strategies. To date, even though based on successful pre-clinical animal studies, results of clinical trials are characterized by dampened effects attributable to difficulties in the study design (patient heterogeneity) and species differences. A combination of complementary therapeutic strategies might be considered pre-requisite for future synergistic approaches. Here, we line out pre-clinical interventions resulting in improved functional neurological outcome after spinal cord injury and track them on their intended way to bedside.
Insights
Experimental therapies for spinal cord injury (SCI) aim to reduce damage, restore nerve function, and promote regeneration. While pre-clinical studies show promise, clinical trials face challenges, suggesting combined strategies are key for future success.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Spinal Cord Injury Research
Background:
- Spinal cord injury (SCI) involves complex secondary damage mechanisms.
- Identification of inhibitory and neurotrophic proteins has spurred numerous therapeutic strategies.
- Current approaches target neuroprotection, neurorestoration, and neuroregeneration.
Purpose of the Study:
- To review pre-clinical therapeutic interventions for spinal cord injury.
- To assess the translation of these interventions from bench to bedside.
- To highlight strategies showing promise in improving functional neurological outcomes.
Main Methods:
- Review of pre-clinical studies on spinal cord injury therapies.
- Analysis of therapeutic targets including growth inhibitor antagonism, growth factor application, cell transplantation, and vaccination.
- Evaluation of factors contributing to dampened clinical trial effects.
Main Results:
- Pre-clinical studies demonstrate potential for functional recovery through various therapeutic avenues.
- Clinical trial outcomes have been less impactful than pre-clinical data due to study design and species differences.
- Combined therapeutic strategies are proposed as essential for synergistic effects.
Conclusions:
- Pre-clinical research offers valuable insights into potential spinal cord injury treatments.
- Bridging the gap between pre-clinical success and clinical efficacy remains a significant challenge.
- Future therapeutic development may benefit from combining complementary strategies for enhanced outcomes.
More Related Videos
07:37Long-Term Mouse Spinal Cord Organotypic Slice Culture as a Platform for Validating Cell Transplantation in Spinal Cord Injury
Published on: April 12, 2024
08:25Investigating Functional Regeneration in Organotypic Spinal Cord Co-cultures Grown on Multi-electrode Arrays
Published on: September 23, 2015
Related Concept Videos
01:15Neurogenesis and Regeneration of Nervous Tissue
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...